TDC
BSTG

Thompson Davis & Co’s Biostage, Inc. Common Stock BSTG Stock Holding History

Thompson Davis & Co’s Portfolio BSTG Stock Details BSTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-7,875
Closed -$71K – 919
2014
Q1 		$71K Sell
7,875
-16,505
-68% -$97.8K 0.12% 205
2013
Q4 		$116K Buy
+24,380
New +$114K 0.18% 136

Other funds holding BSTG

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
HSA
Hussman Strategic Advisors Ellicott City, Maryland $463M AUM 16% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Thompson Davis & Co's BSTG Position: Q2 2014 in Review

Thompson Davis & Co sold out of Biostage, Inc. Common Stock (BSTG) in Q2 2014, closing a stake of 7,875 shares — an estimated $71K sold.

Thompson Davis & Co first reported a position in BSTG in Q4 2013 and held it in 2 quarters. The position peaked at $116K in Q4 2013. 53 funds tracked by Wall St. Rank hold BSTG as of Q2 2014.

  • Thompson Davis & Co reported no remaining Biostage, Inc. Common Stock position as of Q2 2014 after selling out during the quarter.
  • Thompson Davis & Co sold 7,875 Biostage, Inc. Common Stock shares in Q2 2014, an estimated $71K.
  • Thompson Davis & Co first reported a position in Biostage, Inc. Common Stock in Q4 2013 and held it in 2 quarters.
  • Thompson Davis & Co's Biostage, Inc. Common Stock position peaked at $116K in Q4 2013.
  • 53 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q2 2014.

Based on Thompson Davis & Co's 13F filing for Q2 2014, filed 12 Aug 2014.